Treating Prostate Cancer by Antibody–Drug Conjugates

Prostate cancer is the most frequent malignancy in the worldwide male population; it is also one of the most common among all the leading cancer-related death causes. In the last two decades, the therapeutic scenario of metastatic castration-resistant prostate cancer has been enriched by the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosellini, Matteo, Santoni, Matteo, Mollica, Veronica, Rizzo, Alessandro, Cimadamore, Alessia, Scarpelli, Marina, Storti, Nadia, Battelli, Nicola, Montironi, Rodolfo, Massari, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913806/
https://www.ncbi.nlm.nih.gov/pubmed/33557050
http://dx.doi.org/10.3390/ijms22041551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913806/
https://www.ncbi.nlm.nih.gov/pubmed/33557050
http://dx.doi.org/10.3390/ijms22041551

Ejemplares similares